The relationship between peripheral neuropathy and efficacy in second-line chemotherapy for unresectable advanced gastric cancer: a prospective observational multicenter study protocol (IVY)

The relationship between peripheral neuropathy and efficacy in second-line chemotherapy for unresectable advanced gastric cancer: a prospective observational multicenter study protocol (IVY)

Abstract Background Paclitaxel is used in second-line conventional chemotherapies to manage patients with unresectable advanced gastric cancer (GC). Paclitaxel-induced peripheral neuropathy is a known adverse event leading to treatment discontinuation. Additionally, oxaliplatin which causes irrevers...

Full description

Bibliographic Details
Main Authors: Hiroaki Tanioka, Takeshi Nagasaka, Futoshi Uno, Masafumi Inoue, Hiroyuki Okita, Yosuke Katata, Hiromitsu Kanzaki, Hidekazu Kuramochi, Hironaga Satake, Yoshiaki Shindo, Akira Doi, Jyunichiro Nasu, Haruhiro Yamashita, Yoshiyuki Yamaguchi
Format: Article
Language:English
Published: BMC 2019-10-01
Series:BMC Cancer
Subjects:
Gastric cancer
Peripheral neuropathy
Oxaliplatin
Paclitaxel
Online Access:http://link.springer.com/article/10.1186/s12885-019-6163-6

Internet

http://link.springer.com/article/10.1186/s12885-019-6163-6

Similar Items